Date
Cost
Available to
Practice Managers
General Practitioners
Medical Specialist
Continuing Professional Development
RACGP hours pending
Australia is launching a new National Lung Cancer Screening Program in July 2025. This is the second of a series of educational webinars planned for 2025 in preparation of the new program.
This session will cover the fundamentals of pulmonary nodules and assessment of lung cancer risk, as well as management of both screen-detected and non-screen- detected nodules. This session will also provide information about a new service at the Royal Melbourne Hospital to support primary care providers with the commencement of lung cancer screening.
At the end of the session, audience members will be familiar with the different types of pulmonary nodules, how to assess their risk and their management, as well as local resources available.
Speakers:
Dr Asha Bonney is a respiratory and sleep physician at the Royal Melbourne Hospital. Her other roles include Senior Research Fellow at the University of Melbourne, respiratory and sleep physician at Eastern Health, and member of the Thoracic Society of Australia and New Zealand Lung Cancer Working Party. She recently completed a PhD in the field of lung cancer screening and is the clinical lead of the Lung Nodule Clinic at RMH and lead of the Lung Nodule and Screening Program at RMH.
Associate Professor Renee Manser is a respiratory and sleep physician at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre. She has a PhD in lung cancer screening and is an honorary Associate Professor in the Department of Medicine, University of Melbourne. She has extensive clinical experience in lung cancer diagnosis and management and is a principal investigator on the International Lung Screen Trial. A/Prof Manser is co-editor for the Cochrane Lung Cancer Review Group and a regular scientific reviewer for the Melbourne Health Human Research Ethics Committee
Dr Alistair Miller - Royal Melbourne Hospital
Learning outcomes:
By the end of this activity, participants will be able to:
- Distinguish between the different types of pulmonary nodules
- Assess pulmonary nodule risk
- Explain the management of incidental pulmonary nodules
- Describe the new lung cancer screening pulmonary nodule management pathway